澳政府将出资1900万美元用于人类疾病新疗法的研究

  近日，澳大利亚政府表示，他们将计划奖励一个研究团体1910万美元，鼓励其进行基因组学研究来帮助开发预防、诊断及治疗疾病的新疗法。

  这项计划名为“针对性地呼吁澳大利亚进行致力于卫生保健的基因组学革命性研究”，其由澳大利亚国家卫生和医学研究委员会发起，在这项研究计划下，研究小组将接受为期5年的奖励资助来进行研究，用于阐明基因组数据对病人健康护理的影响，同时也可以确定将这些数据纳入到卫生系统后对经济和政策制定的影响。

  研究者表示，这些预期性的研究或将帮助临床医生使用基因组学数据来管理人类的疾病，比如癌症、糖尿病等。

  国家卫生和医学研究委员会的CEO Warwick Anderson表示，在当今的卫生保健领域，我们可以观察到基因组如何在诊断一些疾病上表现出差异的，比如特定的癌症中，而通过有针对性的呼吁所进行的研究也将为我们获取一些信息，其或许可以帮助我们来理解如何更好地使用基因组的强大力量来改善人类的健康，并且不断开发出治疗人类疾病的疗法。（转化医学网360zhyx.com）

  以上为转化医学网原创翻译整理，如需转载，请联系 info@360zhyx.com
转化医学网推荐的新闻阅读：

The Australian government said today that it plans to award A$25 million (US$19.1 million) to one research team to conduct genomics research to prevent, diagnose, and treat diseases.

The program, called Targeted Call for Research into Preparing Australia for the Genomics Revolution in Health Care, was announced today by the National Health and Medical Research Council. Under the program, a research team will receive the five-year award for a project that is expected to elucidate the impact of genomic data on patient care and to identify the economic and policy impacts of incorporating such data into the health system. The research resulting from the award is anticipated to help clinicians use genomics to manage diseases, such as cancer and diabetes, NHMRC said.

"In health care today, we can already see how genomics is making a difference in the diagnosis of some diseases, including certain types of cancers," NHMRC CEO Warwick Anderson said in a statement. "The research conducted through this targeted call for research will yield new knowledge that will help us to understand how best to use the power of genomics to improve patient treatment."